BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 29, 15:52Prev. Close
41.65
Open Price
42.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Balaxi Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 60.99 | 70.20 | 108.14 | 101.29 | 86.87 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 60.99 | 70.20 | 108.14 | 101.29 | 86.87 | |
| Total Operating Revenues | 60.99 | 70.20 | 108.14 | 101.29 | 86.87 | |
| Other Income | 5.37 | 2.40 | 6.60 | 2.75 | 1.81 | |
| Total Revenue | 66.36 | 72.59 | 114.74 | 104.04 | 88.68 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 50.94 | 56.49 | 82.10 | 76.92 | 63.33 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Employee Benefit Expenses | 4.87 | 5.04 | 4.04 | 2.90 | 1.95 | |
| Finance Costs | 2.06 | 1.54 | 0.46 | 0.06 | 0.01 | |
| Depreciation And Amortisation Expenses | 0.46 | 0.51 | 0.52 | 0.25 | 0.09 | |
| Other Expenses | 2.75 | 3.43 | 5.18 | 4.21 | 2.71 | |
| Total Expenses | 61.07 | 67.01 | 92.29 | 84.34 | 68.08 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5.29 | 5.58 | 22.45 | 19.70 | 20.60 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 5.29 | 5.58 | 22.45 | 19.70 | 20.60 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 1.78 | 2.04 | 5.17 | 5.00 | 5.46 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.10 | -0.11 | 1.06 | 0.03 | 0.00 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 1.69 | 1.93 | 6.23 | 5.03 | 5.46 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 3.60 | 3.65 | 16.22 | 14.67 | 15.13 | |
| Profit/Loss From Continuing Operations | 3.60 | 3.65 | 16.22 | 14.67 | 15.13 | |
| Profit/Loss For The Period | 3.60 | 3.65 | 16.22 | 14.67 | 15.13 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 0.65 | 3.55 | 16.17 | 14.67 | 15.13 | |
| Diluted EPS (Rs.) | 0.65 | 3.54 | 16.02 | 14.67 | 15.13 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.08.2025
Balaxi Pharma Consolidated June 2025 Net Sales at Rs 70.74 crore, up 7.8% Y-o-Y
06.08.2025
Balaxi Pharma Standalone June 2025 Net Sales at Rs 16.71 crore, down 12.18% Y-o-Y
24.06.2025
Balaxi Pharma Standalone March 2025 Net Sales at Rs 9.65 crore, down 39.33% Y-o-Y
20.02.2025
Balaxi Pharma Consolidated December 2024 Net Sales at Rs 73.29 crore, up 20.57% Y-o-Y
12.08.2025
Balaxi Pharma Consolidated June 2025 Net Sales at Rs 70.74 crore, up 7.8% Y-o-Y
06.08.2025
Balaxi Pharma Standalone June 2025 Net Sales at Rs 16.71 crore, down 12.18% Y-o-Y
24.06.2025
Balaxi Pharma Standalone March 2025 Net Sales at Rs 9.65 crore, down 39.33% Y-o-Y
20.02.2025
Balaxi Pharma Consolidated December 2024 Net Sales at Rs 73.29 crore, up 20.57% Y-o-Y
15.06.2017
24.04.2017
18.04.2017
18.04.2017
14.02.2017
13.02.2017
12.02.2017
09.12.2016